About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT02195999

Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy

This study seeks to develop and validate non-invasive assessments of cardiac and respiratory muscles with magnetic resonance imaging (MRI) to better predict the natural disease progression of Duchenne...

Lead sponsor: University of Florida•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Florida

Collaborators

CureDuchenne

Magnetic Resonance Imaging (MRI) of the heart and breathing muscles, special breathing tests (called pulmonary function testing), special exercise tests (using a stationary bike), and possibly an echocardiogram (ultrasound of the heart, commonly known as an "echo") will be completed up to 4 times per year for up to 4 years. Most participants will complete testing once or twice each year; however, some participants will be asked to repeat some of the tests twice during each visit.

Age

5 - 15 years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•Male
•5-15 years old at the time of enrollment
•Diagnosed with DMD (as defined by parent project)
•Written parental informed consent (and assent where appropriate) before any study procedures take place

Exclusion Criteria

•Contraindication to an MRI examination
•Presence of a secondary condition that impacts muscle function or metabolism, that leads to developmental delay or impaired motor control, or that is not stable
•Participant is unable to comply with study requirements
•Congenital structural abnormality of the heart, repaired or unrepaired
•Clinically contraindicated participation

Related studies

RECRUITINGPhase 3

The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD

NCT05066633 · Muscular Dystrophy, Duchenne

Active Not RecruitingPhase 3

A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)

NCT03992430 · Muscular Dystrophy, Duchenne

Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping

NCT07250737 · Muscular Disorders, Atrophic, Muscular Diseases, and more

TERMINATEDPhase 2

Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy

NCT05429372 · Muscular Dystrophy, Duchenne

COMPLETEDPhase 2

A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

NCT03406780 · Muscular Dystrophies, Muscular Dystrophy, Duchenne, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 8, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment9

Start dateDec 2013

Last updatedJul 8, 2019

Condition

Muscular Dystrophy, Duchenne

Locations shown

Clinical and Translational Research Building

Gainesville, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 8, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions